Related Experiment Videos
Stent placement in superior vena cava syndrome
Patrick Courtheoux1, Barbara Alkofer, Madjed Al Refaï
1Department of Neuroradiology Surgery, CHRU de Caen, Caen, France.
The Annals of Thoracic Surgery
|January 23, 2003
Summary
Percutaneous stenting effectively relieves superior vena cava syndrome (SVCS) in cancer patients. Repeated stenting is a viable option for symptom recurrence, offering sustained relief.
Area of Science:
- Interventional Cardiology
- Oncology
- Vascular Surgery
Background:
- Superior vena cava syndrome (SVCS) is a critical complication of thoracic malignancies.
- SVCS presents with severe symptoms and carries a poor prognosis.
Purpose of the Study:
- To evaluate the efficacy of percutaneous stenting in the superior vena cava (SVC) for SVCS palliation.
- To assess the feasibility of repeat stenting following symptom recurrence.
Main Methods:
- A cohort of 20 patients with malignant disease-related SVCS underwent SVC stenting.
- The study analyzed procedural success and clinical outcomes.
Main Results:
- Successful SVCS symptom control was achieved in 94% of patients.
- One patient experienced a fatal myocardial infarction unrelated to the stent.
- Repeat stenting was successfully performed in 3 patients due to symptom recurrence.
Conclusions:
- Percutaneous SVC stenting is a safe and effective treatment for malignant SVCS.
- Repeat stenting offers a successful therapeutic option for recurrent SVCS.